English
简体中文
Total: £ 56.28
Published Date: 2025-09-18 | Pages: 83 | Tables: 90 | Medical Care
The global market for Sepsis Rapid Diagnosis was valued at US$ 589 million in the year 2024 and is projected to reach a revised size of US$ 1143 million by 2031, growing at a CAGR of 10.2% during the forecast period.
Sepsis rapid diagnosis refers to the class of in vitro diagnostic technologies and systems designed to identify bloodstream infection or the host’s dysregulated inflammatory response in the shortest possible time within emergency and critical-care settings. This category includes direct-from-blood molecular assays, rapid blood-culture and organism-identification platforms, multiplex nucleic-acid pathogen panels, host-response/biomarker rapid immunoassays, and integrated point-of-care or fast-laboratory workflows. Its core value lies in shrinking time-to-diagnosis from days to hours or minutes, thereby enabling immediate antimicrobial decision-making, risk stratification, and critical-care interventions—improving outcomes and lowering inpatient costs.
Sepsis rapid diagnostics are at an inflection point moving from “technical feasibility” toward “clinical and procurement standardization.” Policy emphasis by governments and international health bodies on early recognition and rapid intervention creates a policy-backed entry for diagnostics with clinical evidence; meanwhile, multiple public diagnostic companies cite rapid molecular and host-response testing as priority growth areas in their annual reports, indicating continued capital and R&D allocation. Hospital demand for shorter decision times, optimized antimicrobial use and improved critical-care outcomes drives procurement away from single-use reagents toward integrated “reagents–platform–digital” solutions. Sell-side and industry research widely note that products delivering immediate, clinically actionable results while addressing cost-effectiveness will be prioritized in large health-system tenders. Despite clear opportunities, the commercialization pathway for rapid diagnostics faces regulatory and implementation challenges. Divergent regulatory, reimbursement, and compliance frameworks across markets require early multi-market registration strategies—an issue highlighted in corporate annual reports. Clinical evidence generation and real-world implementation studies are critical adoption gates. Moreover, the stability of upstream reagents and disposables, interoperability with laboratory informatics, and the ability to embed devices into clinical pathways materially affect rollout speed and customer satisfaction; weaknesses in any component can substantially delay hospital-scale deployment. Healthcare customers demonstrate a concurrent demand for speed, actionability, and integrated services: EDs and ICUs prioritize minute-to-hour diagnostics, elevating POC and rapid molecular tests into core emergency workflows; antimicrobial stewardship and infection-control teams expect test results to directly trigger antimicrobial start/stop and stratified treatment, raising requirements for report interpretation and decision-support. Governmental and hospital quality programs—evidenced in annual reports and public guidance—are increasingly incorporating sepsis testing into institutional quality metrics and procurement priorities, shifting buyer evaluation from price-only to a comprehensive assessment of clinical value and implementation services. The upstream supply base for sepsis rapid diagnostics includes high-grade reagent enzymes and nucleic-acid extraction kits, disposable microfluidic cartridges or chips, capture/label antibodies and lateral-flow materials, and the sensitive electronics and software modules required by platforms. Annual reports indicate reagents and single-use consumables are margin drivers and scaling levers; localizing and diversifying supply chains directly impacts tender competitiveness and delivery timelines. Platform vendors also emphasize sustained investment in hardware–software integration and data analytics (including AI), implying that upstream investment extends beyond raw materials into proprietary processes and digital capabilities—core sources of future differentiation and a durable moat for incumbents.
This report aims to provide a comprehensive presentation of the global market for Sepsis Rapid Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis Rapid Diagnosis.
The Sepsis Rapid Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sepsis Rapid Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sepsis Rapid Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Thermo Fisher Scientific
bioMérieux
Danaher
Roche
QuantaMatrix
Abbott Laboratories
T2 Biosystems
Immunexpress
Qiagen
Response Biomedical
Mindray
Siemens Healthineers
Segment by Type
Blood Culture
Molecular Testing
Bacterial Examination
Other
Segment by Application
Hospital
Third-party Laboratory
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sepsis Rapid Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Rapid Diagnosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Culture
1.2.3 Molecular Testing
1.2.4 Bacterial Examination
1.2.5 Other
1.3 Market by Application
1.3.1 Global Sepsis Rapid Diagnosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Third-party Laboratory
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Rapid Diagnosis Market Perspective (2020-2031)
2.2 Global Sepsis Rapid Diagnosis Growth Trends by Region
2.2.1 Global Sepsis Rapid Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sepsis Rapid Diagnosis Historic Market Size by Region (2020-2025)
2.2.3 Sepsis Rapid Diagnosis Forecasted Market Size by Region (2026-2031)
2.3 Sepsis Rapid Diagnosis Market Dynamics
2.3.1 Sepsis Rapid Diagnosis Industry Trends
2.3.2 Sepsis Rapid Diagnosis Market Drivers
2.3.3 Sepsis Rapid Diagnosis Market Challenges
2.3.4 Sepsis Rapid Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Rapid Diagnosis Players by Revenue
3.1.1 Global Top Sepsis Rapid Diagnosis Players by Revenue (2020-2025)
3.1.2 Global Sepsis Rapid Diagnosis Revenue Market Share by Players (2020-2025)
3.2 Global Top Sepsis Rapid Diagnosis Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sepsis Rapid Diagnosis Revenue
3.4 Global Sepsis Rapid Diagnosis Market Concentration Ratio
3.4.1 Global Sepsis Rapid Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Rapid Diagnosis Revenue in 2024
3.5 Global Key Players of Sepsis Rapid Diagnosis Head office and Area Served
3.6 Global Key Players of Sepsis Rapid Diagnosis, Product and Application
3.7 Global Key Players of Sepsis Rapid Diagnosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Rapid Diagnosis Breakdown Data by Type
4.1 Global Sepsis Rapid Diagnosis Historic Market Size by Type (2020-2025)
4.2 Global Sepsis Rapid Diagnosis Forecasted Market Size by Type (2026-2031)
5 Sepsis Rapid Diagnosis Breakdown Data by Application
5.1 Global Sepsis Rapid Diagnosis Historic Market Size by Application (2020-2025)
5.2 Global Sepsis Rapid Diagnosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sepsis Rapid Diagnosis Market Size (2020-2031)
6.2 North America Sepsis Rapid Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sepsis Rapid Diagnosis Market Size by Country (2020-2025)
6.4 North America Sepsis Rapid Diagnosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sepsis Rapid Diagnosis Market Size (2020-2031)
7.2 Europe Sepsis Rapid Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sepsis Rapid Diagnosis Market Size by Country (2020-2025)
7.4 Europe Sepsis Rapid Diagnosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Rapid Diagnosis Market Size (2020-2031)
8.2 Asia-Pacific Sepsis Rapid Diagnosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sepsis Rapid Diagnosis Market Size by Region (2020-2025)
8.4 Asia-Pacific Sepsis Rapid Diagnosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Sepsis Rapid Diagnosis Market Size (2020-2031)
9.2 Latin America Sepsis Rapid Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sepsis Rapid Diagnosis Market Size by Country (2020-2025)
9.4 Latin America Sepsis Rapid Diagnosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Rapid Diagnosis Market Size (2020-2031)
10.2 Middle East & Africa Sepsis Rapid Diagnosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sepsis Rapid Diagnosis Market Size by Country (2020-2025)
10.4 Middle East & Africa Sepsis Rapid Diagnosis Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Sepsis Rapid Diagnosis Introduction
11.1.4 BD Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.1.5 BD Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Sepsis Rapid Diagnosis Introduction
11.2.4 Thermo Fisher Scientific Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 bioMérieux
11.3.1 bioMérieux Company Details
11.3.2 bioMérieux Business Overview
11.3.3 bioMérieux Sepsis Rapid Diagnosis Introduction
11.3.4 bioMérieux Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.3.5 bioMérieux Recent Development
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher Sepsis Rapid Diagnosis Introduction
11.4.4 Danaher Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.4.5 Danaher Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Sepsis Rapid Diagnosis Introduction
11.5.4 Roche Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.5.5 Roche Recent Development
11.6 QuantaMatrix
11.6.1 QuantaMatrix Company Details
11.6.2 QuantaMatrix Business Overview
11.6.3 QuantaMatrix Sepsis Rapid Diagnosis Introduction
11.6.4 QuantaMatrix Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.6.5 QuantaMatrix Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Sepsis Rapid Diagnosis Introduction
11.7.4 Abbott Laboratories Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.7.5 Abbott Laboratories Recent Development
11.8 T2 Biosystems
11.8.1 T2 Biosystems Company Details
11.8.2 T2 Biosystems Business Overview
11.8.3 T2 Biosystems Sepsis Rapid Diagnosis Introduction
11.8.4 T2 Biosystems Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.8.5 T2 Biosystems Recent Development
11.9 Immunexpress
11.9.1 Immunexpress Company Details
11.9.2 Immunexpress Business Overview
11.9.3 Immunexpress Sepsis Rapid Diagnosis Introduction
11.9.4 Immunexpress Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.9.5 Immunexpress Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Sepsis Rapid Diagnosis Introduction
11.10.4 Qiagen Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.10.5 Qiagen Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Sepsis Rapid Diagnosis Introduction
11.11.4 Response Biomedical Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.11.5 Response Biomedical Recent Development
11.12 Mindray
11.12.1 Mindray Company Details
11.12.2 Mindray Business Overview
11.12.3 Mindray Sepsis Rapid Diagnosis Introduction
11.12.4 Mindray Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.12.5 Mindray Recent Development
11.13 Siemens Healthineers
11.13.1 Siemens Healthineers Company Details
11.13.2 Siemens Healthineers Business Overview
11.13.3 Siemens Healthineers Sepsis Rapid Diagnosis Introduction
11.13.4 Siemens Healthineers Revenue in Sepsis Rapid Diagnosis Business (2020-2025)
11.13.5 Siemens Healthineers Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sepsis Rapid Diagnosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Blood Culture
Table 3. Key Players of Molecular Testing
Table 4. Key Players of Bacterial Examination
Table 5. Key Players of Other
Table 6. Global Sepsis Rapid Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Sepsis Rapid Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Sepsis Rapid Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Sepsis Rapid Diagnosis Market Share by Region (2020-2025)
Table 10. Global Sepsis Rapid Diagnosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Sepsis Rapid Diagnosis Market Share by Region (2026-2031)
Table 12. Sepsis Rapid Diagnosis Market Trends
Table 13. Sepsis Rapid Diagnosis Market Drivers
Table 14. Sepsis Rapid Diagnosis Market Challenges
Table 15. Sepsis Rapid Diagnosis Market Restraints
Table 16. Global Sepsis Rapid Diagnosis Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Sepsis Rapid Diagnosis Market Share by Players (2020-2025)
Table 18. Global Top Sepsis Rapid Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Rapid Diagnosis as of 2024)
Table 19. Ranking of Global Top Sepsis Rapid Diagnosis Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Sepsis Rapid Diagnosis Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Sepsis Rapid Diagnosis, Headquarters and Area Served
Table 22. Global Key Players of Sepsis Rapid Diagnosis, Product and Application
Table 23. Global Key Players of Sepsis Rapid Diagnosis, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Sepsis Rapid Diagnosis Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Sepsis Rapid Diagnosis Revenue Market Share by Type (2020-2025)
Table 27. Global Sepsis Rapid Diagnosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Sepsis Rapid Diagnosis Revenue Market Share by Type (2026-2031)
Table 29. Global Sepsis Rapid Diagnosis Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Sepsis Rapid Diagnosis Revenue Market Share by Application (2020-2025)
Table 31. Global Sepsis Rapid Diagnosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Sepsis Rapid Diagnosis Revenue Market Share by Application (2026-2031)
Table 33. North America Sepsis Rapid Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Sepsis Rapid Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Sepsis Rapid Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Sepsis Rapid Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Sepsis Rapid Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Sepsis Rapid Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Sepsis Rapid Diagnosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Sepsis Rapid Diagnosis Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Sepsis Rapid Diagnosis Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Sepsis Rapid Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Sepsis Rapid Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Sepsis Rapid Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Sepsis Rapid Diagnosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Sepsis Rapid Diagnosis Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Sepsis Rapid Diagnosis Market Size by Country (2026-2031) & (US$ Million)
Table 48. BD Company Details
Table 49. BD Business Overview
Table 50. BD Sepsis Rapid Diagnosis Product
Table 51. BD Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 52. BD Recent Development
Table 53. Thermo Fisher Scientific Company Details
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Sepsis Rapid Diagnosis Product
Table 56. Thermo Fisher Scientific Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. bioMérieux Company Details
Table 59. bioMérieux Business Overview
Table 60. bioMérieux Sepsis Rapid Diagnosis Product
Table 61. bioMérieux Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 62. bioMérieux Recent Development
Table 63. Danaher Company Details
Table 64. Danaher Business Overview
Table 65. Danaher Sepsis Rapid Diagnosis Product
Table 66. Danaher Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 67. Danaher Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Sepsis Rapid Diagnosis Product
Table 71. Roche Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 72. Roche Recent Development
Table 73. QuantaMatrix Company Details
Table 74. QuantaMatrix Business Overview
Table 75. QuantaMatrix Sepsis Rapid Diagnosis Product
Table 76. QuantaMatrix Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 77. QuantaMatrix Recent Development
Table 78. Abbott Laboratories Company Details
Table 79. Abbott Laboratories Business Overview
Table 80. Abbott Laboratories Sepsis Rapid Diagnosis Product
Table 81. Abbott Laboratories Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 82. Abbott Laboratories Recent Development
Table 83. T2 Biosystems Company Details
Table 84. T2 Biosystems Business Overview
Table 85. T2 Biosystems Sepsis Rapid Diagnosis Product
Table 86. T2 Biosystems Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 87. T2 Biosystems Recent Development
Table 88. Immunexpress Company Details
Table 89. Immunexpress Business Overview
Table 90. Immunexpress Sepsis Rapid Diagnosis Product
Table 91. Immunexpress Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 92. Immunexpress Recent Development
Table 93. Qiagen Company Details
Table 94. Qiagen Business Overview
Table 95. Qiagen Sepsis Rapid Diagnosis Product
Table 96. Qiagen Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 97. Qiagen Recent Development
Table 98. Response Biomedical Company Details
Table 99. Response Biomedical Business Overview
Table 100. Response Biomedical Sepsis Rapid Diagnosis Product
Table 101. Response Biomedical Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 102. Response Biomedical Recent Development
Table 103. Mindray Company Details
Table 104. Mindray Business Overview
Table 105. Mindray Sepsis Rapid Diagnosis Product
Table 106. Mindray Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 107. Mindray Recent Development
Table 108. Siemens Healthineers Company Details
Table 109. Siemens Healthineers Business Overview
Table 110. Siemens Healthineers Sepsis Rapid Diagnosis Product
Table 111. Siemens Healthineers Revenue in Sepsis Rapid Diagnosis Business (2020-2025) & (US$ Million)
Table 112. Siemens Healthineers Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Sepsis Rapid Diagnosis Picture
Figure 2. Global Sepsis Rapid Diagnosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sepsis Rapid Diagnosis Market Share by Type: 2024 VS 2031
Figure 4. Blood Culture Features
Figure 5. Molecular Testing Features
Figure 6. Bacterial Examination Features
Figure 7. Other Features
Figure 8. Global Sepsis Rapid Diagnosis Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Sepsis Rapid Diagnosis Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Third-party Laboratory Case Studies
Figure 12. Other Case Studies
Figure 13. Sepsis Rapid Diagnosis Report Years Considered
Figure 14. Global Sepsis Rapid Diagnosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Sepsis Rapid Diagnosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Sepsis Rapid Diagnosis Market Share by Region: 2024 VS 2031
Figure 17. Global Sepsis Rapid Diagnosis Market Share by Players in 2024
Figure 18. Global Sepsis Rapid Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Sepsis Rapid Diagnosis Revenue in 2024
Figure 20. North America Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Sepsis Rapid Diagnosis Market Share by Country (2020-2031)
Figure 22. United States Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Sepsis Rapid Diagnosis Market Share by Country (2020-2031)
Figure 26. Germany Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Ireland Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Sepsis Rapid Diagnosis Market Share by Region (2020-2031)
Figure 34. China Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia & New Zealand Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Sepsis Rapid Diagnosis Market Share by Country (2020-2031)
Figure 42. Mexico Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Sepsis Rapid Diagnosis Market Share by Country (2020-2031)
Figure 46. Israel Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Sepsis Rapid Diagnosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. BD Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 51. bioMérieux Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 52. Danaher Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 53. Roche Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 54. QuantaMatrix Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 55. Abbott Laboratories Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 56. T2 Biosystems Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 57. Immunexpress Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 58. Qiagen Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 59. Response Biomedical Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 60. Mindray Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 61. Siemens Healthineers Revenue Growth Rate in Sepsis Rapid Diagnosis Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
